Kaleido Biosciences (NASDAQ:KLDO) Downgraded by Morgan Stanley to Underweight

Kaleido Biosciences} stock has undergone multiple analysts rating changes in the recent past.  Kaleido Biosciences Downgraded by Morgan Stanley on 10/19/2021. In a note to investors, the firm issued a new rating of Underweight. The analysts previously had rating of Equal Weight.

View More Kaleido Biosciences (NASDAQ:KLDO) Downgraded by Morgan Stanley to Underweight